SpyGlass Pharma, Inc. financial statements
SpyGlass Pharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 39.87M | 10-K |
| Cash and equivalents | USD 96.36M | 10-Q |
| Total debt | USD 1.58M | EODHD |
SpyGlass Pharma, Inc. financials on 6ix · SpyGlass Pharma, Inc. on 6ix